Posted in | News | Gold

Platinex and Creso Exploration Report Sampling Results from Gold Corona-Pet Vein Pit Zones

Platinex and Creso Exploration have announced the fresh grab and channel sampling results from the Gold Corona-Pet Vein zones, which is situated at its Gold Corona property in Ontario.

Gold Corona-Pet Vein has encountered up to 5.4 g/t gold over 1.80 m during channel sampling and the Pet Vein pit’s channel samples have turned out 26 g/t gold over 1.35 m.

The samples from the Pet Vein pit has been gathered by draining the flooded pit of 4 m deep, wherein the grab samples have yielded up to 181 g/t gold. The location of the well mineralized Pet Vein material stock of around 3-5 t was contiguous to the Pet Pit. A character sample of 10.5 kg has produced 26.3 g/t gold using Gravimetric, FAA313 Fire Assay and Metallic Screen test. It has been scheduled for additional digging of the pit to form the mineralized zone’s controlling geometry to target the diamond drilling.

Platinex’s CEO and President, has commented that the Gold Corona property brings numerous well-known excellent gold veins in a thick chemical metasedimentary rocks. The mineralization in the Pet veins and Gold Corona offers drive for continuing a huge tonnage of low-grade deposit at the surface and an extended high-grade body at the depth.

The CEO and President of the Creso, has said that the company is delighted to see the progress of Gold Corona JV property with the favourable results of surface sampling.

Source: http://www.platinex.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Platinex Inc.. (2019, February 18). Platinex and Creso Exploration Report Sampling Results from Gold Corona-Pet Vein Pit Zones. AZoMining. Retrieved on April 23, 2024 from https://www.azomining.com/News.aspx?newsID=5025.

  • MLA

    Platinex Inc.. "Platinex and Creso Exploration Report Sampling Results from Gold Corona-Pet Vein Pit Zones". AZoMining. 23 April 2024. <https://www.azomining.com/News.aspx?newsID=5025>.

  • Chicago

    Platinex Inc.. "Platinex and Creso Exploration Report Sampling Results from Gold Corona-Pet Vein Pit Zones". AZoMining. https://www.azomining.com/News.aspx?newsID=5025. (accessed April 23, 2024).

  • Harvard

    Platinex Inc.. 2019. Platinex and Creso Exploration Report Sampling Results from Gold Corona-Pet Vein Pit Zones. AZoMining, viewed 23 April 2024, https://www.azomining.com/News.aspx?newsID=5025.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.